Anosmia Market Analysis By Type(Idiopathic Anosmia, Congenital Anosmia), By Treatment Type(Therapies, Medications), By End User(Hospitals, Clinics) & Forecast 2024-2035
- PUBLISHED ON
- 15/03/2023
- NO OF PAGES
- 245
- CATEGORY
- Healthcare & Life Sciences
The growing incidence of anosmia cases is anticipated to drive the global anosmia market during the forecasted period. Anosmia is a partial or total loss of sense of smell. For example, an article issued by the ENT UK at The Royal College of Surgeons of England in 2020, accounts that the latest COVID-19 virus causes anosmia in diseased patients. Besides, the same source, ENT UK at The Royal College of Surgeons of England in 2020, also states that 30% of patients in South Korea, had anosmia. Likewise, as per the same source in Germany, it is stated that over 2 in 3 confirmed cases have anosmia. In the United States, 3% of people aged more than 40 are affected by anosmia.
Moreover, increasing research activities for new drug developments is projected to boost the global Anosmia market during the forecasted period. Increasing research activities by the market players to grow an advanced treatment for anosmia is estimated to drive the global anosmia market growth over the forecasted period. For example, in June 2019, Washington University School of Medicine, initiated the Phase II study, to estimate the efficiency and security of Budesonide in patients with coronavirus smell therapy for anosmia recovery. The study is anticipated to complete in December 2023. For example, ClinAmygate developing for Anosmia and/or Ageusia in COVID-19 Treatment with Early Corticosteroid (Dexamethasone) and Recovery is in Phase 4 clinical trials which will upsurge the need for the anosmia market.
The covid-19 pandemic outburst has boosted the need to estimate the anosmia market to treat Covid-19 infections. Chemosensory disorders like loss of smell or taste, are the utmost neurological symptom of COVID-19. Above 80% of COVID-19 patients display some change in chemesthesis, containing smell. Anosmia has also been more common of COVID-19 than all other indications, including cough or fatigue, fever, based on a survey of 2 million members in the UK and US. Google examines for "smell," "loss of smell," "anosmia," and other similar terms growing as the early months of the pandemic and intensely correlated with upsurges in daily cases and deaths. Examination into the mechanisms underlying these indications is presently enduring. Several nations already listed anosmia as an official COVID-19 symptom, and some have established "smell tests" as possible screening tools. For example, in 2020, the Global Consortium for Chemosensory Research, a collective research organization of global smell and taste researchers, was designed to examine the loss of smell and related chemosensory signs.
Type Insights
Based on the type, the global anosmia market is bifurcated into idiopathic anosmia, congenital anosmia. Idiopathic anosmia denotes to patients in whom, after extensive analysis, no cause for the loss of sense of smell is established. This diagnosis must be prepared only after blood tests and brain scans have been completed. Patients in this group may go on to grow Parkinson’s and Alzheimer’s diseases. For example, an article issued by the Fifth Sense in 2020 reports that between the familiar smell loss disorders, idiopathic anosmia holds around 25%, and congenital anosmia holds a share of 1% in the U.K.
Congenital anosmia is an unusual type, some people are born lacking a sense of smell, which is a disorder called congenital anosmia. It occurs when there is either an inherited genetic disorder or abnormal development of the olfactory system (the body’s sensory system for smell) occurring before birth. But there is no medication for congenital anosmia.
Treatment Type Insights
Based on the treatment type, the global anosmia market is segmented into treatments, medicines, and others. The medicines segment accounts for the major share of the market. Decongestant’s medicines work by instigating blood vessels to limit and help to release congestion caused by the enlargement of blood vessels in the nasal channels. Phenylephrine and phenylpropanolamine are two common drug formulas. These OTC drugs can bring momentary relief from congestion.
Antihistamines work by declining the effects of histamine on specific cell receptors. First-generation OTC oral antihistamines, containing diphenhydramine and chlorpheniramine. Nasal corticosteroids relieve congestion by deteriorating the swelling in the nose. Unlike inhaled corticosteroids used for asthma, nasal versions are sprayed straight into the nasal passages. Nasal corticosteroids are generally accessible in spray form. They’re also presented as aerosol liquids and powders. For example, the University of Anbar developed a drug to analyse the effect of nasal steroids in considering anosmia due to COVID-19 disease by drug Ophtamesone is in early phase 1 trial.
End User Insights
Based on end-user, the global anosmia market is segmented into hospitals, clinics, others. Owing to the rising patient population, the hospital's segment held the leading market share. This is mostly owing to the growing number of patients suffering from situations that are treated in hospitals prepared with advanced substructure and adequate amenities. Furthermore, the rising number of hospitals along with proper reimbursement policies is also donating to the growth of this segment. Also, the surgery is done under the administration of medical practitioners at these situations.
Region Insights
North America served the major share in the global anosmia market over the forecasted period, due to growing cases of anosmia in the region. For example, an article issued by the National Center for Biotechnology Information (NCBI) in 2017 accounts that a substantial portion, i.e., about 4.3 million people, 65 years or older, suffer from anosmia U.S. The presence of an extremely established healthcare system, the high grade of approval by medical practitioners of latest treatments, the total accessibility of innovative technological tools, FDA authorization of novel drugs. For example, Washington University School of Medicine directing a Phase 2 study of Smell in Covid-19 and Efficacy of Nasal Theophylline is anticipated to complete by 2021.
However, the Asia Pacific is anticipated to be the fastest-growing market during the forecasted period due to the growing prevalence rate, surging focus on preventive care, and government initiatives encouraging technological innovations.
Key Companies Insights
The market for anosmia is moderately competitive. With the rising applications of anosmia, new players are considering to enter the market. The companies are also involved in events like joint ventures, acquisitions, partnerships, mergers, and collaborations. These activities aid in growing the effect of the players in the anosmia market, ultimately boosting the market growth.
• Mylan N.V.
• Pfizer Inc.
• Atom Pharma
• Ranbaxy Laboratories Limited
• Alde Medi Impex
• GlaxoSmithKline plc
• Sandoz (Novartis AG)
• Cadila Pharmaceuticals
• Taj Pharmaceuticals Limited
• Sanofi
• Other players
Some of the Recent Developments:
• In June 2020, Cadila Pharmaceuticals Limited introduced Bilastine syrup (30 ml) and Bilastine tablets (20 mg), an antihistamine drug. This drug is utilized in the treatment of allergic rhinitis, which later develops anosmia.
• In 2020, Pfizer partnered with BioNTech to examine and grow COVID-19 mRNA vaccine candidates. On July 27, 2020, the firms started a global (except China) Phase 2/3 safety and efficiency clinical study to estimate the mRNA vaccine candidate BNT162b2. The corporations plan to use Pfizer facilities to produce the vaccine if they get FDA approval.
Segments
By Type
• Idiopathic Anosmia
• Congenital Anosmia
By Treatment Type
• Therapies
o Nasal Endoscopy
o Imaging
• Medications
o Decongestants
o Antihistamines
o Steroid
o Nasal Sprays
• Others
By End User
• Hospitals
• Clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Historic Year: 2016-2022
Forecast: 2024-2035
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI